Back
  1. Home
  2. Profile of Maude PIRON (ULiège)
Profil

PIRON Maude

Département de médecine interne > Service d'oncologie médicale

See author's contact details
Main Referenced Co-authors
Beguin, Yves  (2)
Dujardin, C. (1)
Fillet, Georges  (1)
Gothot, André  (1)
Loo, Martine (1)
Main Referenced Keywords
Anemia/chemically induced (1); Animals (1); Bone Marrow Cells/drug effects/metabolism (1); Erythroid Precursor Cells/drug effects (1); Erythropoiesis/drug effects (1);
Main Referenced Disciplines
Hematology (2)

Publications (total 2)

The most downloaded
831 downloads
Piron, M., Loo, M., Gothot, A., Tassin, F., Fillet, G., & Beguin, Y. (2001). Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia. Blood, 97 (2), 442-8. doi:10.1182/blood.V97.2.442 https://hdl.handle.net/2268/6959

The most cited

29 citations (Scopus®)

Piron, M., Loo, M., Gothot, A., Tassin, F., Fillet, G., & Beguin, Y. (2001). Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia. Blood, 97 (2), 442-8. doi:10.1182/blood.V97.2.442 https://hdl.handle.net/2268/6959

Beguin, Y., Dujardin, C., Piron, M., & Vanstraelen, G. (2006). Treatment of anaemia with erythropoietin. In C. Brugnara & C. Beaumont, ESH Scientific Updates. Disorders of Iron Homeostasis, Erythrocytes and erythropoiesis (pp. 180-209). Elsevier Science.

Piron, M., Loo, M., Gothot, A., Tassin, F., Fillet, G., & Beguin, Y. (2001). Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia. Blood, 97 (2), 442-8. doi:10.1182/blood.V97.2.442
Peer Reviewed verified by ORBi

Contact ORBi